One day, next-generation gene therapies could be used to nudge the body’s own cells to make those proteins at precisely the right time and in just the right amount. ÃÛÌÇÖ±²¥ Boulder biochemistry professor Robert Batey and Alexandria Forbes, Ph.D., founder and CEO of New York-based biotech firm MeiraGTx, are teaming up to explore how to do it.